Search

everythinglearnresearchcommunity

for

Search:↓

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Higher SHBG levels are linked to less severe hair loss in women, but vitamin D levels don't seem to affect hair loss.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

Women with acne have lower levels of a specific hormone marker than women without acne.

AMH levels in adolescents with PCOS are not affected by their weight.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Birth control pills can help reduce mild to moderate acne in women.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

There is no significant link between male pattern baldness and insulin resistance.

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.